Sergio R. B.
- Country
- Spain
- Department
- Servicio de enfermedades infecciosas
Research Overview
- Lenacapavir with Teropavimab and Zinlirvimab (twice‑yearly) versus Cabotegravir/Rilpivirine in virologically suppressed adults with HIV‑1
- Evaluation of the Antiviral Efficacy and Safety of GSK3739937 in Treatment-Naïve Adults with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Study
- Assessment of Efficacy and Safety of Switching from Boosted Protease Inhibitor to Fostemsavir Trometamol in HIV-1 Patients with Limited Therapeutic Options
Data & Insights
Has run more than one trial at 29 of 93 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in advancing therapeutic approaches for HIV-1 infection, with particular emphasis on treatment strategies for patients with limited therapeutic options and innovative drug delivery systems.
- Protease inhibitor alternatives
- Long-acting antiretroviral therapy
- Novel antiviral compounds
Their research extends to exploring treatment solutions for specific patient populations, including elderly individuals living with HIV.
Treatment-Resistant HIV Management
Focused on developing therapeutic solutions for treatment-experienced patients who face challenges with conventional HIV therapies, including the evaluation of novel drug compounds like fostemsavir.
- Alternative treatment pathways
- Viral load management
- Treatment switching strategies
The investigator's work addresses critical needs in managing complex HIV cases requiring specialized therapeutic approaches.
Emerging Therapeutic Approaches
Actively involved in investigating novel antiretroviral compounds and treatment methodologies, including the evaluation of experimental therapies for treatment-naive HIV-1 infected individuals.
- Monotherapy evaluations
- Treatment-naive patient care
- Antiviral efficacy assessment
Their research encompasses both short-term proof-of-concept studies and long-term therapeutic evaluations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.